We are live on
!
Find out more
Immunic
IMUX
IMUX
51 hedge funds and large institutions have $51M invested in Immunic in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,500% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 2
291% more capital invested
Capital invested by funds: $13M → $51M (+$38M)
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
143% more funds holding
Funds holding: 21 → 51 (+30)
0.8% more ownership
Funds ownership: 2.01% → 2.81% (+0.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
51
Holders Change
+30
Holders Change %
+142.86%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
10
Reduced
4
Closed
2
Calls
$676K
Puts
–
Net Calls
+$676K
Net Calls Change
+$343K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.41M |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$2.01M |
| 3 |
BlackRock
New York
|
+$1.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.78M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.66M |
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$305K |
| 2 |
Millennium Management
New York
|
-$61K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$21.8K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$16K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.77K |
